Specialty pharmaceutical company Supernus Pharmaceuticals has announced the launch of Oxtellar XR tablets in the US. Oxtellar XR, a once-daily extended release formulation of oxcarbazepine, is an antiepileptic drug (AED), which is ...
Supernus Pharmaceuticals has received approval from the FDA for its Oxtellar XR, a new once-daily extended release formulation of oxcarbazepine. Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in ...
Tags: oxcarbazepine, FDA approval, partial seizure, pharmaceutical product